These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 33953680)

  • 1. Research Progress on Strategies that can Enhance the Therapeutic Benefits of Mesenchymal Stromal Cells in Respiratory Diseases With a Specific Focus on Acute Respiratory Distress Syndrome and Other Inflammatory Lung Diseases.
    Rolandsson Enes S; Krasnodembskaya AD; English K; Dos Santos CC; Weiss DJ
    Front Pharmacol; 2021; 12():647652. PubMed ID: 33953680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesenchymal stromal cells for acute respiratory distress syndrome (ARDS), sepsis, and COVID-19 infection: optimizing the therapeutic potential.
    Gorman E; Millar J; McAuley D; O'Kane C
    Expert Rev Respir Med; 2021 Mar; 15(3):301-324. PubMed ID: 33172313
    [No Abstract]   [Full Text] [Related]  

  • 3. Current understanding of the therapeutic benefits of mesenchymal stem cells in acute respiratory distress syndrome.
    Lopes-Pacheco M; Robba C; Rocco PRM; Pelosi P
    Cell Biol Toxicol; 2020 Feb; 36(1):83-102. PubMed ID: 31485828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MSCs interaction with the host lung microenvironment: An overlooked aspect?
    Weiss DJ; Rolandsson Enes S
    Front Immunol; 2022; 13():1072257. PubMed ID: 36458013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent insights: mesenchymal stromal/stem cell therapy for acute respiratory distress syndrome.
    Horie S; Laffey JG
    F1000Res; 2016; 5():. PubMed ID: 27408702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell therapy in acute respiratory distress syndrome.
    Horie S; Gonzalez HE; Laffey JG; Masterson CH
    J Thorac Dis; 2018 Sep; 10(9):5607-5620. PubMed ID: 30416812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stem cell therapy for acute respiratory distress syndrome: a promising future?
    Horie S; Masterson C; Devaney J; Laffey JG
    Curr Opin Crit Care; 2016 Feb; 22(1):14-20. PubMed ID: 26645555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fresh and Cryopreserved Human Umbilical-Cord-Derived Mesenchymal Stromal Cells Attenuate Injury and Enhance Resolution and Repair following Ventilation-Induced Lung Injury.
    Horie S; Gonzalez H; Brady J; Devaney J; Scully M; O'Toole D; Laffey JG
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. When Origin Matters: Properties of Mesenchymal Stromal Cells From Different Sources for Clinical Translation in Kidney Disease.
    Calcat-I-Cervera S; Sanz-Nogués C; O'Brien T
    Front Med (Lausanne); 2021; 8():728496. PubMed ID: 34616756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesenchymal stem cell derived secretome and extracellular vesicles for acute lung injury and other inflammatory lung diseases.
    Monsel A; Zhu YG; Gudapati V; Lim H; Lee JW
    Expert Opin Biol Ther; 2016 Jul; 16(7):859-71. PubMed ID: 27011289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic Benefits of Mesenchymal Stem Cells in Acute Respiratory Distress Syndrome: Potential Mechanisms and Challenges.
    Cao C; Zhang L; Liu F; Shen J
    J Inflamm Res; 2022; 15():5235-5246. PubMed ID: 36120184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in understanding mesenchymal stromal cells.
    Rendra E; Scaccia E; Bieback K
    F1000Res; 2020; 9():. PubMed ID: 32148780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-based therapies for the acute respiratory distress syndrome.
    Maron-Gutierrez T; Laffey JG; Pelosi P; Rocco PR
    Curr Opin Crit Care; 2014 Feb; 20(1):122-31. PubMed ID: 24300620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospects and progress in cell therapy for acute respiratory distress syndrome.
    Cruz FF; Weiss DJ; Rocco PR
    Expert Opin Biol Ther; 2016 Nov; 16(11):1353-1360. PubMed ID: 27487721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesenchymal Stromal Cells in Viral Infections: Implications for COVID-19.
    Rocha JLM; de Oliveira WCF; Noronha NC; Dos Santos NCD; Covas DT; Picanço-Castro V; Swiech K; Malmegrim KCR
    Stem Cell Rev Rep; 2021 Feb; 17(1):71-93. PubMed ID: 32895900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene engineered mesenchymal stem cells: greater transgene expression and efficacy with minicircle vs. plasmid DNA vectors in a mouse model of acute lung injury.
    Florian M; Wang JP; Deng Y; Souza-Moreira L; Stewart DJ; Mei SHJ
    Stem Cell Res Ther; 2021 Mar; 12(1):184. PubMed ID: 33726829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current Status of Cell-Based Therapies for COVID-19: Evidence From Mesenchymal Stromal Cells in Sepsis and ARDS.
    Xu Z; Huang Y; Zhou J; Deng X; He W; Liu X; Li Y; Zhong N; Sang L
    Front Immunol; 2021; 12():738697. PubMed ID: 34659231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strategies to Enhance Mesenchymal Stem Cell-Based Therapies for Acute Respiratory Distress Syndrome.
    Han J; Li Y; Li Y
    Stem Cells Int; 2019; 2019():5432134. PubMed ID: 31885615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional enhancement strategies to potentiate the therapeutic properties of mesenchymal stromal cells for respiratory diseases.
    Lopes-Pacheco M; Rocco PRM
    Front Pharmacol; 2023; 14():1067422. PubMed ID: 37007034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesenchymal Stromal Cells Attenuate Infection-Induced Acute Respiratory Distress Syndrome in Animal Experiments: A Meta-Analysis.
    Fengyun W; LiXin Z; Xinhua Q; Bin F
    Cell Transplant; 2020; 29():963689720969186. PubMed ID: 33164559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.